Lyme Disease
This is an excerpt from the paper...
This report investigates Lyme disease, with a focus on anatomic and physiological aspects, stages of the disease with bodily effects, how the disease mimics other diseases, and treatments. Lyme disease (LD) has a history of more than 100 years in the Old World. In the 1970s, LD was the adopted term for the multisystem nature of Lyme arthritis. Lyme arthritis was described in 1975 as a juvenile rheumatoid arthritis, usually preceded by a distinctive skin rash, erythema chronicum migrans (ECM, now called erythema migrans, EM). Spirochete, isolated from Ixodes dammini ticks, was associated with the spread of the disease in 1982. The cause of the disease was established as the spirochete and named Borrelia burgdorferi (Bb). Three species of Borrelia cause LD: Borrelia burgdorferi sensu stricto (United States and Europe), Borrelia garinii, and Borrelia afzelii (Europe). A syndrome consisting of lymphocytic meningitis, radiculitis, and cranial nerve palsy was described by Garin-Bujadoux and Bannwarth. This syndrome is related to a preceding ECM and bite by Ixodes ricinus; it was called tick-borne meningopolyneuritis (Gannwarth syndrome). The bacterial pathogen suspected is now called Bb (Sigal, 1997). LD is a zoonotic infection occurring in enzootic cycles among wildlife; it affects humans when they are bitten by an infected tick. LD affects all age groups and may involve the skin, joints, nervous system, and heart. Most human cases of
. . .
later in infection, at the point when anti-ospA reactivity is identified. OspA (induces IL-6 production) vaccination has been effective in mice; other Bb proteins used as vaccines are ospB, C, E, and F. Bb has mitogenic activity for B cells; polyclonal B cell activation is identified in patient sera. Animal models suggest that T cells are involved in LD pathogenesis; Bb has an effect on T cells. Bb is a potent immunomodulator; Bbs suppress local immune responses (Sigal, 1997).
Stages & Body Effects
LD is divided into three categories of clinical features and amount of time passed since acquisition of infection. Separate stages may overlap. Days to a month after a tick bite, erythema migrans (EM) at the site of the bite, occurs in 50 percent to 80 percent of patients; multiple lesions occur in around 50 percent of EM patients. This early localized LD phase is accompanied with non-specific symptoms that are compatible with a viral syndrome (50 percent of patients). Symptoms include fatigue/malaise/lethargy, headache, myalgia, arthralgias, and regional/generalized lymphadenopathy (Sigal, 1996; 1997).
In a matter of weeks to around nine months, 10 percent to 15 percent of those not receiving antibiotic therapy progress t
. . .
Some common words found in the essay are:
LD LD, Dam Rothova, Effects LD, Bb Bb, Bb Sigal, LD Manifestations, Stages LD, DISEASE Introduction, Late LD, LD Failure, lyme disease, sigal 1996, sigal 1997, 50 percent, misdiagnosed ld, nervous system, sigal 1996 1997, 1996 1997, ld mimics, dam rothova 1993, dam rothova, van dam, van dam rothova, kijlstra van dam, kuiper kijlstra van,
Approximate Word count = 1865
Approximate Pages = 7 (250 words per page)
More Essays on Lyme Disease
|